Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/14/04 → 8/12/05 |
Funding
- Monitoring Force USA, Inc. (EMR 62 225)
- Merck KGaA (EMR 62 225)
Prot# EMR 62 225: Feasibility Study on the Use of A Parkinson's Disease Symptoms Diary for the Planned Phase III Studies with Sarizotan (EMR 62 225)
- Simuni, Tatyana (PD/PI)
Project: Research project